Ytterbium-176 Isotope

Access Ytterbium-176 isotope enriched to over 99.5%, delivered in metal or oxide form, for the production of Lutetium-177 used in oncology for targeted cancer radiotherapies.
    • Produce 177Lu from enriched ¹⁷⁶Yb isotope
    • Meet the growing demand for targeted radionuclide therapy in cancer treatment
    • Ensure isotopic purity
    • Secure access to a strategic precursor for your clinical and industrial needs
    • Plan for future scale-up with a reliable European industrial partner
    • Access enrichment levels above 99.5% for ¹⁷⁶Yb using the SILVA process, laser isotope separation technology developed with the CEA and tailored for lanthanides
    • Get a solution suited to the production of ¹⁷⁷Lu for next-generation oncology treatments
    • Choose the chemical form that fits your processes (metal or oxide)
    • Rely on a secure European supply chain, with production at the Tricastin site
    Robust European supply chain
    Metal or oxide form
    • >99.5% enrichment of ¹⁷⁶Yb via laser isotopic separation (SILVA)
    • SILVA process developed in partnership with the CEA
    • European production site: Tricastin, France
    • Available forms: metal or oxide
    • High isotopic purity meeting radiopharmaceutical needs

    Exploded view of the Stable Isotopes Laboratory

  • Website Orano Stable Isotopes